<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40982417</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The effect of a six-month programme of intradialytic cycling on survival and hospitalisations in people requiring haemodialysis: 5-year follow-up of the CYCLE-HD randomised controlled trial.</ArticleTitle><Pagination><StartPage>e0332389</StartPage><MedlinePgn>e0332389</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0332389</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0332389</ELocationID><Abstract><AbstractText>We have previously shown that a six-month programme of intradialytic cycling (IDC) improved cardiovascular structure and function, it is unclear whether these changes are associated with long-term benefits. The aim of this post-trial analysis was to evaluate a programme of IDC on all-cause mortality, hospitalisations and cardiovascular events at five-years. Mortality and hospitalisation data were collected from Hospital Episode Statistics and death certificates. Models were fitted unadjusted and adjusted for age, sex, diabetes, duration of dialysis, and receiving a kidney transplant. Cox proportional hazard models were used for time-to-event analysis to evaluate all-cause mortality. Hospitalisations were analysed using a negative binomial regression model, and length of stay using a generalised linear model. A composite outcome of time to first cardiovascular event, combining cardiovascular mortality and hospitalisations, was evaluated using a Cox model. There was no evidence of a statistically significant effect of treatment allocation on survival (hazard ratio (HR) 1.09, 95% confidence interval (CI): 0.68-1.76, p&#x2009;=&#x2009;0.71). After adjustment, results remained non-significant (HR 1.22, 95% CI: 0.74-2.01, p&#x2009;=&#x2009;0.43). There was no evidence of a significant effect on all-cause hospitalisations for unadjusted (p&#x2009;=&#x2009;0.20) or adjusted (p&#x2009;=&#x2009;0.25) models. Similar results are reported for cardiovascular hospitalisations (p&#x2009;=&#x2009;0.30 and p&#x2009;=&#x2009;0.17). For time to first cardiovascular event there was no evidence of a statistically significant effect (HR 1.39, 95% CI: 0.79-2.72, p&#x2009;=&#x2009;0.26). The main findings show no evidence that a six-month programme of IDC affected all-cause mortality, hospitalisations, cardiovascular events, or length of stay in hospital at five-years.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Adenwalla et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adenwalla</LastName><ForeName>Sherna F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worboys</LastName><ForeName>Hannah M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration East Midlands, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawday</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration East Midlands, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leicester British Heart Foundation Centre of Research Excellence, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hull</LastName><ForeName>Katherine L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0003-0028-5408</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Churchward</LastName><ForeName>Darren R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Highton</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration East Midlands, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leicester Diabetes Centre, College of Life Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Hannah M L</ForeName><Initials>HML</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leicester Diabetes Centre, College of Life Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham-Brown</LastName><ForeName>Matthew P M</ForeName><Initials>MPM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burton</LastName><ForeName>James O</ForeName><Initials>JO</Initials><Identifier Source="ORCID">0000-0003-1176-7592</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>March</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-1468-6918</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>JOB and LJG are both funded (Senior Investigator Awards) by the National Institute for Health and Care Research (NIHR). LG and HW are funded by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and Leicester NIHR Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. For the purpose of open access, the author has applied a Creative Commons Attribution license (CC BY) to any Author Accepted Manuscript version arising from this submission.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>22</Day><Hour>18</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>22</Day><Hour>18</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>22</Day><Hour>13</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40982417</ArticleId><ArticleId IdType="pmc">PMC12453264</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0332389</ArticleId><ArticleId IdType="pii">PONE-D-25-28929</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11443763</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38519262</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham-Brown MP, Patel A, Stensel D, March DS, Marsh A-M, McAdam J. Imaging of myocardial fibrosis in patients with end&#x2010;stage renal disease: current limitations and future possibilities. BioMed Research International. 2017;2017(1):5453606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352874</ArticleId><ArticleId IdType="pubmed">28349062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008;4(12):672&#x2013;81. doi: 10.1038/ncpneph0954</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneph0954</ArticleId><ArticleId IdType="pubmed">18825155</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914&#x2013;20. doi: 10.2215/CJN.03900808</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03900808</ArticleId><ArticleId IdType="pmc">PMC2676185</ArticleId><ArticleId IdType="pubmed">19357245</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham-Brown MPM, March DS, Young R, Highton PJ, Young HML, Churchward DR, et al. A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass. Kidney Int. 2021;99(6):1478&#x2013;86. doi: 10.1016/j.kint.2021.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.02.027</ArticleId><ArticleId IdType="pubmed">34023029</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker LA, March DS, Wilkinson TJ, Billany RE, Bishop NC, Castle EM, et al. Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol. 2022;23(1):75. doi: 10.1186/s12882-021-02618-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-021-02618-1</ArticleId><ArticleId IdType="pmc">PMC8862368</ArticleId><ArticleId IdType="pubmed">35193515</ArticleId></ArticleIdList></Reference><Reference><Citation>Stack AG, Molony DA, Rives T, Tyson J, Murthy BVR. Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis. 2005;45(4):690&#x2013;701. doi: 10.1053/j.ajkd.2004.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2004.12.013</ArticleId><ArticleId IdType="pubmed">15806472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissell RB, et al. Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant. 2010;25(9):3050&#x2013;62. doi: 10.1093/ndt/gfq138</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq138</ArticleId><ArticleId IdType="pubmed">20392706</ArticleId></ArticleIdList></Reference><Reference><Citation>Anding-Rost K, von Gersdorff G, von Korn P, Ihorst G, Josef A, Kaufmann M, et al. Exercise during Hemodialysis in Patients with Chronic Kidney Failure. NEJM Evid. 2023;2(9):EVIDoa2300057. doi: 10.1056/EVIDoa2300057</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/EVIDoa2300057</ArticleId><ArticleId IdType="pubmed">38320198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallamaci F, D&#x2019;Arrigo G, Tripepi G, Lamberti N, Torino C, Manfredini F, et al. Long-term effect of physical exercise on the risk for hospitalization and death in dialysis patients: a post-trial long-term observational study. Clinical Journal of the American Society of Nephrology. 2022;17(8):1176&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9435990</ArticleId><ArticleId IdType="pubmed">35878932</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredini F, D&#x2019;arrigo G, Lamberti N, Torino C, Tripepi G, Mallamaci F, et al. The legacy effect of a home walking exercise programme in kidney failure patients on dialysis. Nephrol Dial Transplant. 2022;37(10):1974&#x2013;81. doi: 10.1093/ndt/gfac147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfac147</ArticleId><ArticleId IdType="pubmed">35641182</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JL, Slentz CA, Ross LM, Huffman KM, Kraus WE. Ten-Year Legacy Effects of Three Eight-Month Exercise Training Programs on Cardiometabolic Health Parameters. Front Physiol. 2019;10:452. doi: 10.3389/fphys.2019.00452</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00452</ArticleId><ArticleId IdType="pmc">PMC6476955</ArticleId><ArticleId IdType="pubmed">31040797</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham-Brown MPM, March DS, Churchward DR, Young HML, Dungey M, Lloyd S, et al. Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial. BMC Nephrol. 2016;17(1):69. doi: 10.1186/s12882-016-0294-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-016-0294-7</ArticleId><ArticleId IdType="pmc">PMC4938939</ArticleId><ArticleId IdType="pubmed">27391774</ArticleId></ArticleIdList></Reference><Reference><Citation>Association U. 26th annual report. 2024. https://www.ukkidney.org/audit-research/annual-report</Citation></Reference><Reference><Citation>Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515&#x2013;26.</Citation></Reference><Reference><Citation>UK Renal Registry. UK Renal Registry 25th Annual Report- data to 31/12/2021. Bristol, UK; 2023.</Citation></Reference><Reference><Citation>March DS, Lai K-B, Neal T, Graham-Brown MPM, Highton PJ, Churchward DR, et al. Circulating endotoxin and inflammation: associations with fitness, physical activity and the effect of a 6-month programme of cycling exercise during haemodialysis. Nephrol Dial Transplant. 2022;37(2):366&#x2013;74. doi: 10.1093/ndt/gfab178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfab178</ArticleId><ArticleId IdType="pubmed">33983449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson TJ, Clarke AL, Nixon DGD, Hull KL, Song Y, Burton JO, et al. Prevalence and correlates of physical activity across kidney disease stages: an observational multicentre study. Nephrol Dial Transplant. 2021;36(4):641&#x2013;9. doi: 10.1093/ndt/gfz235</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz235</ArticleId><ArticleId IdType="pubmed">31725147</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, et al. Association of physical activity with survival among ambulatory patients on dialysis: the Comprehensive Dialysis Study. Clin J Am Soc Nephrol. 2013;8(2):248&#x2013;53. doi: 10.2215/CJN.08560812</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.08560812</ArticleId><ArticleId IdType="pmc">PMC3562868</ArticleId><ArticleId IdType="pubmed">23124787</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredini F, Mallamaci F, D&#x2019;Arrigo G, Baggetta R, Bolignano D, Torino C, et al. Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. J Am Soc Nephrol. 2017;28(4):1259&#x2013;68. doi: 10.1681/ASN.2016030378</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016030378</ArticleId><ArticleId IdType="pmc">PMC5373448</ArticleId><ArticleId IdType="pubmed">27909047</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabibi MA, Cheema B, Salimian N, Corr&#xea;a H de L, Ahmadi S. The effect of intradialytic exercise on dialysis patient survival: a randomized controlled trial. BMC Nephrol. 2023;24(1):100. doi: 10.1186/s12882-023-03158-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-023-03158-6</ArticleId><ArticleId IdType="pmc">PMC10108498</ArticleId><ArticleId IdType="pubmed">37069527</ArticleId></ArticleIdList></Reference><Reference><Citation>March DS, Hurt AW, Grantham CE, Churchward DR, Young HML, Highton PJ, et al. A Cost-Effective Analysis of the CYCLE-HD Randomized Controlled Trial. Kidney Int Rep. 2021;6(6):1548&#x2013;57. doi: 10.1016/j.ekir.2021.02.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2021.02.036</ArticleId><ArticleId IdType="pmc">PMC8207470</ArticleId><ArticleId IdType="pubmed">34169195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>